Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Balancing risks of surgical complications and positive margins for patients with invasive lobular carcinoma of the breast and elevated BMI: An institutional cohort study.
Falade I, Switalla K, Quirarte A, Baxter M, Soroudi D, Rothschild H, Abe SE, Goodwin K, Piper M, Alvarado M, Julian BQ, Ewing C, Wong J, Rose J, Esserman L, Foster R, Mukhtar RA. Falade I, et al. Among authors: mukhtar ra. Am J Surg. 2024 Nov 6;241:116073. doi: 10.1016/j.amjsurg.2024.116073. Online ahead of print. Am J Surg. 2024. PMID: 39571369 Free article.
Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy.
Jacob S, Christofferson A, Fisch S, Norwood P, Castillo P, Yu H, Hirst G, Soliman H, Nanda R, Mukhtar RA, Ewing C, Majure M, Melisko M, Rugo HS, Esserman L, Price E, Chien AJ. Jacob S, et al. Among authors: mukhtar ra. Breast Cancer Res Treat. 2024 Sep 21. doi: 10.1007/s10549-024-07481-w. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 39305392
Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and Common Among Patients with HER2+ Breast Cancer.
Tchou J, Gottipati S, Goldbach M, Baxter M, Venters S, Balassanian R, Vohra P, Gonzalves D, Ahmad Z, Nayak A, Boughey JC, Mukhtar RA, Chen YY. Tchou J, et al. Among authors: mukhtar ra. Ann Surg Oncol. 2024 Nov;31(12):8093-8101. doi: 10.1245/s10434-024-15889-3. Epub 2024 Aug 8. Ann Surg Oncol. 2024. PMID: 39117925 Free PMC article.
Magnetic resonance imaging insights from active surveillance of women with ductal carcinoma in situ.
Greenwood HI, Maldonado Rodas CK, Freimanis RI, Glencer AC, Miller PN, Mukhtar RA, Brabham C, Yau C, Rosenbluth JM, Hirst GL, Campbell MJ, Borowsky A, Hylton N, Esserman LJ, Basu A. Greenwood HI, et al. Among authors: mukhtar ra. NPJ Breast Cancer. 2024 Aug 4;10(1):71. doi: 10.1038/s41523-024-00677-9. NPJ Breast Cancer. 2024. PMID: 39098868 Free PMC article.
Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle TM, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar RA. Switalla KM, et al. Among authors: mukhtar ra. Ann Surg Oncol. 2024 Oct;31(11):7249-7259. doi: 10.1245/s10434-024-15792-x. Epub 2024 Jul 12. Ann Surg Oncol. 2024. PMID: 38995451 Free PMC article.
Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial.
Piltin MA, Norwood P, Ladores V, Mukhtar RA, Sauder CA, Golshan M, Tchou J, Rao R, Lee MC, Son J, Reyna C, Hewitt K, Kuerer H, Ahrendt G, Greenwalt I, Tseng J, Postlewait L, Howard-McNatt M, Jaskowiak N, Esserman LJ, Boughey JC; , ISPY2 Locoregional Working Group. Piltin MA, et al. Among authors: mukhtar ra. Ann Surg Oncol. 2024 Oct;31(11):7420-7428. doi: 10.1245/s10434-024-15708-9. Epub 2024 Jul 9. Ann Surg Oncol. 2024. PMID: 38980586
84 results